PR Newswire
PALO ALTO, Calif., Sept. 19, 2017
PALO ALTO, Calif., Sept. 19, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced it will be demonstrating its new Halcyon™ platform for simplifying and enhancing virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), and HyperArc™ high-definition radiotherapy (HDRT), an advanced type of radiosurgery treatment, September 24-27 in San Diego, CA at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, booth 717. The company also will be hosting its Users Meeting on Saturday, September 23 prior to the ASTRO meeting.
In addition to Halcyon and HyperArc, Varian will showcase these solutions for simplifying and increasing access to advanced cancer care:
The Varian Users Meeting will provide attendees with new insights on the latest Varian technology. Topics include:
A complete Users Meeting agenda is available online at http://www.varian.com/news/usermeeting.
When: ASTRO is September 24– 27, 2017. The exhibition is open from 10:00am to 5:00pm Sunday through Tuesday.
Where: | San Diego Convention Center |
| Booth # 717 |
| San Diego, CA |
About Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,600 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
View original content:http://www.prnewswire.com/news-releases/varian-to-showcase-latest-technologies-and-software-for-advanced-cancer-care-at-astro-2017-300521703.html
SOURCE Varian Medical Systems
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.